Oracle's Valuation Gap Widens as Options Traders Turn Bullish

ORCL closed Tuesday at $140.35 — down 14% on the week and nearly 7% over the past month — yet the options market is now leaning more bullish than it has in months, creating an unusual divergence that defines this week's setup.

The most striking shift is in options positioning. Call demand has overtaken the recent norm: the put/call ratio dropped to 0.78, almost two standard deviations below its 20-day average of 0.85. That's the most call-heavy reading in recent weeks and sits well below the midpoint of the 52-week range (0.57–1.06). After the prolonged defensive posture that characterized the pre-earnings period — flagged in prior notes — options traders have swung in the opposite direction, accumulating calls into weakness rather than buying downside protection. Whether that reflects genuine conviction or mechanical rebalancing after two earnings-driven drawdowns is the open question.

Short interest has retreated and tells a quiet story on its own. At roughly 1.6% of the free float, short interest is down about 7.5% on the week and nearly 12% over the past month — continuing the retreat noted in last week's reports. Borrow availability is effectively unlimited: the lending pool holds more than 2.28 billion shares available against just 44.7 million borrowed, an availability ratio that essentially caps out the data range. Cost to borrow has crept higher — up about 41% on the week to 0.35% — but in absolute terms remains trivially cheap. The ORTEX short score has eased to 30.3 from 31.2 a week ago, consistent with short sellers stepping back rather than pressing a thesis. Positioning here is anything but crowded on the bear side.

The Street remains structurally bullish but has spent the past week adjusting its math. Following the Q1 FY2027 earnings reaction — the stock fell 7% on September 10 — analysts broadly held Buy ratings while trimming price targets. Stifel dropped to $200 from $220, BMO cut to $195 from $220, and Freedom Broker trimmed to $205 on September 14. On the other side, UBS raised to $250 and Barclays lifted to $252, both maintaining positive ratings. The consensus mean target is near $239, implying roughly 70% upside from current levels — a gap that has widened materially as the stock has fallen. Guggenheim's $400 target remains a significant outlier that inflates that figure. The bull case rests on AI infrastructure demand — cloud revenue up 41% year-on-year, AI-specific revenue up 243% — and a raised FY27 revenue guidance of $90 billion. Bears point to competitive pressure in the database market, execution risk on AI monetization, and currency headwinds on Oracle's substantial international revenue base. The EPS momentum factor score ranks in the 79th percentile on a 30-day basis and 69th on 90 days, suggesting forward estimates are still rising even as the stock falls — a widening gap between fundamental trajectory and price action.

Valuation multiples have compressed sharply with the decline. The trailing PE has dropped to 14.3x, down nearly 1.9 turns on the week and over a full turn over 30 days. EV/EBITDA has fallen to 8.5x, down half a point on the week. For a company with 41% cloud revenue growth and three-digit AI infrastructure growth rates, those multiples are meaningfully below where enterprise software peers typically trade. Whether that gap between fundamental momentum and multiple compression closes via price recovery or downward estimate revision is what the next quarter's print — currently expected December 7 — will need to answer.

The Ellison episode covered in Sunday's report — the aborted $7.5 billion sale filing, cancelled within 24 hours — has settled without a new filing, and the founder's stated position remains that he holds no plans to sell. He controls 38.3% of shares outstanding. That dynamic hasn't changed materially since Sunday, but it forms part of the backdrop: any renewed filing would reset the technical overhang immediately. The combination of a buyback-eligible valuation, still-rising forward estimates, and the most call-bullish options setup in months makes the December earnings print the natural next focal point for positioning.